CSBR - Champions Oncology, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
4/29/2019
4/29/2018
4/29/2017
4/29/2016
Total Revenue
27,579
27,067
20,241
15,411
11,182
Cost of Revenue
14,934
14,265
10,553
9,703
8,686
Gross Profit
12,645
12,802
9,688
5,708
2,496
Operating Expenses
Research Development
5,013
4,798
4,401
4,293
4,194
Selling General and Administrative
8,457
7,734
6,641
8,224
8,618
Total Operating Expenses
13,522
12,571
11,131
12,517
12,812
Operating Income or Loss
-877
231
-1,443
-6,809
-10,316
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-88
-56
-38
Income Before Tax
-877
231
-1,443
-6,865
-10,354
Income Tax Expense
118
103
33
19
92
Income from Continuing Operations
-995
128
-1,476
-6,884
-10,446
Net Income
-995
128
-1,476
-6,884
-10,446
Net Income available to common shareholders
-995
128
-1,476
-6,884
-10,446
Reported EPS
Basic
-
0.01
-0.14
-0.63
-1.20
Diluted
-
0.01
-0.14
-0.63
-1.20
Weighted average shares outstanding
Basic
-
11,340
11,003
10,982
8,705
Diluted
-
14,096
11,003
10,982
8,705
EBITDA
-
837
-1,083
-6,641
-10,160